|Bid||221.03 x 800|
|Ask||221.38 x 800|
|Day's range||217.14 - 223.30|
|52-week range||170.36 - 248.30|
|Beta (5Y monthly)||0.63|
|PE ratio (TTM)||80.40|
|Earnings date||31 Jan 2022 - 04 Feb 2022|
|Forward dividend & yield||1.72 (0.78%)|
|Ex-dividend date||22 Nov 2021|
|1y target est||258.00|
DUBLIN, IRELAND, Jan. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 third quarter financial results at 10:00 a.m. ET on February 9, 2022. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The ongoing integration of Cantel Medical business and robust demand from medical device customers are expected to have contributed to STERIS' (STE) Q3 performance.